Facing Antitubercular Resistance: Identification of Potential Direct Inhibitors Targeting InhA Enzyme and Generation of 3D-pharmacophore Model by in silico Approach-Reference-Cited by-同舟云学术

Facing Antitubercular Resistance: Identification of Potential Direct Inhibitors Targeting InhA Enzyme and Generation of 3D-pharmacophore Model by in silico Approach

Published:2023-04 Issue: Volume:Volume 16 Page:49-59
ISSN:1178-6949
Container-title:Advances and Applications in Bioinformatics and Chemistry
language:en
Short-container-title:AABC

Author:

EL Haddoumi Ghyzlane^ORCID,Mansouri Mariam^ORCID,Bendani Houda^ORCID,Bouricha El Mehdi^ORCID,Kandoussi Ilham,Belyamani Lahcen,Ibrahimi Azeddine

Publisher

Informa UK Limited

Subject

Computer Science Applications,Biochemistry, Genetics and Molecular Biology (miscellaneous),Biochemistry,Chemistry (miscellaneous)

Reference48 articles.

1. Global Tuberculosis Report 2022. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022. Accessed December 31, 2022.

2. 248 - Prévalence de la tuberculose et infection VIH en milieu carcéral, Antananarivo Madagascar

3. inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis

4. Enzymic Characterization of the Target for Isoniazid in Mycobacterium tuberculosis

5. The Chemical Approach to the Control of Tuberculosis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of broad-spectrum antibacterial efficacy of quercetin by molecular docking, molecular dynamics simulation and in vitro studies;Chemical Physics Impact;2024-06

2. Targeting decaprenylphosphoryl-β-D-ribose 2′-epimerase for Innovative Drug Development Against Mycobacterium Tuberculosis Drug-Resistant Strains;Bioinformatics and Biology Insights;2024-01

3. Overcoming Resistance in Cancer Therapy: Computational Exploration of PIK3CA Mutations, Unveiling Novel Non-Toxic Inhibitors, and Molecular Insights Into Targeting PI3Kα;Bioinformatics and Biology Insights;2024-01